We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
Kidney Cancer Drugs Outlook 2023-2028 - US Market Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 18 days · 18 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 18 days • 1 price levels
Price Analysis
Most common price: £520 (18 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 18 days
Description
Key Features
Provides latent demand outlooks for kidney cancer drugs across the United States from 2023 to 2028.
Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for approximately 12,600 cities.
Delivers comparative benchmarks by reporting the percent share of each city relative to its state and the entire country.
Uses econometric models to assist in the development of effective sales force and distribution strategies.
Offers detailed geographic data to help gauge specific city markets against national and state averages.
Product Specifications
- Format
- paperback
- ASIN
- B0BLGBZQGT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
India Cancer Supportive Care Drugs Outlook 2023-2028
The 2023-2028 Outlook for Cancer Screenings in the United States
The 2016-2021 Outlook for Kidney Dialysis Equipment and Supplies in the United States
The 2023-2028 Outlook for Cancer Supportive Care in the United States
The 2023 Report on End Stage Renal Diseases: World Market Segmentation by City
The 2023-2028 Outlook for Kidney /Renal Function Tests in China
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2016-2021 Outlook for Kidney Dialysis Equipment and Supplies in Greater China
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States
The 2023-2028 Outlook for Cancer Testing-Screening in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2016-2021 Outlook for Kidney Dialysis Equipment and Supplies in Japan
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
The 2013-2018 Outlook for Kidney Dialysis Centers in India
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
The 2023 Report on Kidney Dialysis Equipment and Supplies: World Market Segmentation by City
The 2025-2030 World Outlook for Kidney /Renal Function Tests
Price unavailable
Renal Cancer: Old and New Paradigms, An Issue of Urologic Clinics: Volume 50-2 (The Clinics: Surgery, Volume 50-2)
Elsevier
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
